These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 18838565)

  • 1. Chronic actions of a novel oral B-type natriuretic peptide conjugate in normal dogs and acute actions in angiotensin II-mediated hypertension.
    Cataliotti A; Chen HH; Schirger JA; Martin FL; Boerrigter G; Costello-Boerrigter LC; James KD; Polowy K; Miller MA; Malkar NB; Bailey KR; Burnett JC
    Circulation; 2008 Oct; 118(17):1729-36. PubMed ID: 18838565
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral human brain natriuretic peptide activates cyclic guanosine 3',5'-monophosphate and decreases mean arterial pressure.
    Cataliotti A; Schirger JA; Martin FL; Chen HH; McKie PM; Boerrigter G; Costello-Boerrigter LC; Harty G; Heublein DM; Sandberg SM; James KD; Miller MA; Malkar NB; Polowy K; Burnett JC
    Circulation; 2005 Aug; 112(6):836-40. PubMed ID: 16061734
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of prolonged baroreflex activation on arterial pressure in angiotensin hypertension.
    Lohmeier TE; Dwyer TM; Hildebrandt DA; Irwin ED; Rossing MA; Serdar DJ; Kieval RS
    Hypertension; 2005 Nov; 46(5):1194-200. PubMed ID: 16216987
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human brain natriuretic peptide reduces blood pressure in normotensive and acute norepinephrine-induced hypertensive rabbits.
    Clemens LE; Almirez RG; Baudouin KA; Grossbard EB; Protter AA
    Am J Hypertens; 1997 Jun; 10(6):654-61. PubMed ID: 9194512
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Maintenance of baseline angiotensin II potentiates insulin hypertension in rats.
    Keen HL; Brands MW; Smith MJ; Hall JE
    Hypertension; 1998 Feb; 31(2):637-42. PubMed ID: 9461234
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics and biological actions of subcutaneously administered human brain natriuretic peptide.
    Clemens LE; Almirez RG; Baudouin KA; Mischak RP; Grossbard EB; Protter AA
    J Pharmacol Exp Ther; 1998 Oct; 287(1):67-71. PubMed ID: 9765323
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thromboxane is required for full expression of angiotensin hypertension in rats.
    Keen HL; Brands MW; Smith MJ; Shek EW; Hall JE
    Hypertension; 1997 Jan; 29(1 Pt 2):310-4. PubMed ID: 9039120
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Maximizing the renal cyclic 3'-5'-guanosine monophosphate system with type V phosphodiesterase inhibition and exogenous natriuretic peptide: a novel strategy to improve renal function in experimental overt heart failure.
    Chen HH; Huntley BK; Schirger JA; Cataliotti A; Burnett JC
    J Am Soc Nephrol; 2006 Oct; 17(10):2742-7. PubMed ID: 16928803
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Renal interstitial hydrostatic pressure and natriuretic response to high doses of angiotensin II in pregnant rats.
    Yu T; Khraibi AA
    Am J Hypertens; 2006 Mar; 19(3):300-5. PubMed ID: 16500518
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Examination of the in vivo cardiac electrophysiological effects of nesiritide (human brain natriuretic peptide) in conscious dogs.
    Fenelon G; Protter AA; Stambler BS
    J Card Fail; 2002 Oct; 8(5):320-5. PubMed ID: 12411983
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pressure natriuresis and angiotensin II in reduced kidney mass, salt-induced hypertension.
    Hall JE; Mizelle HL; Brands MW; Hildebrandt DA
    Am J Physiol; 1992 Jan; 262(1 Pt 2):R61-71. PubMed ID: 1733341
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Renal, endocrine, and hemodynamic effects of human brain natriuretic peptide in normal man.
    Holmes SJ; Espiner EA; Richards AM; Yandle TG; Frampton C
    J Clin Endocrinol Metab; 1993 Jan; 76(1):91-6. PubMed ID: 8380606
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the long-term effects of candesartan and olmesartan on plasma angiotensin II and left ventricular mass index in patients with hypertension.
    Tsutamoto T; Nishiyama K; Yamaji M; Kawahara C; Fujii M; Yamamoto T; Horie M
    Hypertens Res; 2010 Feb; 33(2):118-22. PubMed ID: 19927151
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The antifibrotic agent pirfenidone inhibits angiotensin II-induced cardiac hypertrophy in mice.
    Yamazaki T; Yamashita N; Izumi Y; Nakamura Y; Shiota M; Hanatani A; Shimada K; Muro T; Iwao H; Yoshiyama M
    Hypertens Res; 2012 Jan; 35(1):34-40. PubMed ID: 21866107
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of long-term increases in plasma ANP on angiotensin II-induced hypertension.
    Granger JP; Blaine EH; Stacy DL; La Rock MJ
    Am J Physiol; 1990 May; 258(5 Pt 2):H1427-31. PubMed ID: 2140020
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hemodynamics and blood volume in angiotensin II salt-dependent hypertension in dogs.
    Krieger JE; Roman RJ; Cowley AW
    Am J Physiol; 1989 Nov; 257(5 Pt 2):H1402-12. PubMed ID: 2589496
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endopeptidase inhibition in angiotensin-induced hypertension. Effect of SCH 39370 in sheep.
    Charles CJ; Espiner EA; Richards AM; Sybertz EJ
    Hypertension; 1995 Jul; 26(1):89-94. PubMed ID: 7607738
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute phosphodiesterase 5 inhibition mimics hemodynamic effects of B-type natriuretic peptide and potentiates B-type natriuretic peptide effects in failing but not normal canine heart.
    Forfia PR; Lee M; Tunin RS; Mahmud M; Champion HC; Kass DA
    J Am Coll Cardiol; 2007 Mar; 49(10):1079-88. PubMed ID: 17349888
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of angiotensin-converting enzyme inhibition on plasma brain natriuretic peptide levels in patients with heart failure.
    Lang CC; Motwani JG; Rahman AR; Coutie WJ; Struthers AD
    Clin Sci (Lond); 1992 Aug; 83(2):143-7. PubMed ID: 1327628
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Renal function in the AT1A receptor knockout mouse during normal and volume-expanded conditions.
    Cervenka L; Mitchell KD; Oliverio MI; Coffman TM; Navar LG
    Kidney Int; 1999 Nov; 56(5):1855-62. PubMed ID: 10571794
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.